Ocular Therapeutix Inc

NASDAQ:OCUL   1:00:00 PM EDT
3.02
+0.01 (+0.33%)
1:30:34 PM EDT: $3.17 +0.15 (+4.97%)
Earnings Announcements

Ocular Therapeutix Inc Reports Q3 Loss Per Share Of $0.31

Published: 11/07/2022 21:35 GMT
Ocular Therapeutix Inc (OCUL) - Ocular Therapeutix™ Reports Third Quarter 2022 Financial Results and Business Update.
Q3 Loss per Share $0.31.
Q3 Earnings per Share View $-0.24 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $12.64 Million
Adjusted EPS is expected to be -$0.29

Next Quarter Revenue Guidance is expected to be $16.33 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.